GlassScriptPhysician profile
Wendy Renee Easter
NPI 1639782659
$2,568.72
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $589 · 2023: $1,152 · 2024: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,968 · Education: $11.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,968.41 |
| Education | $11.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $581.37 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $363.56 | 2023-2024 | Repatha, Otezla |
| Lilly USA, LLC | $247.44 | 2022-2024 | Mounjaro |
| Pfizer INC. | $242.25 | 2023-2024 | |
| Abbvie INC. | $165.85 | 2022-2024 | |
| Optinose US, INC. | $155.58 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.60 | 2024 | |
| Angiodynamics, INC. | $121.11 | 2023 | Auryon Laser System 100-120 Vac |
| Esperion Therapeutics, INC. | $95.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $94.99 | 2023-2024 | Farxiga, Airsupra |
| Abbott Laboratories | $84.46 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Exact Sciences Corporation | $48.53 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $44.06 | 2022 | |
| Mylan Specialty L.P. | $37.17 | 2023 | Yupelri |
| Horizon Therapeutics Plc | $35.62 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $35.28 | 2023-2024 | Bexsero, Pediarix, Rotarix |
| Viiv Healthcare Company | $28.68 | 2022 | |
| Qorumpartners | $16.18 | 2022 | |
| Coala Life INC | $15.89 | 2023 | Coala Heart Monitor |
| Otsuka America Pharmaceutical, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Easter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.